South and Central America Protein Expression Market to Grow at a CAGR of 8.2% to reach US$ 158.8 million Million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South and Central America Protein Expression Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South and Central America Protein Expression Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Advances in protein research for therapeutic purposes
5.1.2 Growing demand for recombinant proteins in research

5.2 Market Opportunities

5.2.1 Increase in research funding for protein expression
5.2.2 Growth in pharmaceutical applications and protein-based therapeutics

5.3 Future Trends

5.3.1 Improved protein expression systems for large-scale production
5.3.2 Faster protein synthesis

5.4 Impact of Drivers and Restraints

6. South and Central America Protein Expression Market Regional Analysis

6.1 South and Central America Protein Expression Market Overview

6.2 South and Central America Protein Expression Market Revenue 2019-2028 (US$ Million)

6.3 South and Central America Protein Expression Market Forecast Analysis

7. South and Central America Protein Expression Market Analysis – by Product

7.1 Competent Cells

7.1.1 Overview
7.1.2 Competent Cells: South and Central America Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Expression Vectors

7.2.1 Overview
7.2.2 Expression Vectors: South and Central America Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Reagents

7.3.1 Overview
7.3.2 Reagents: South and Central America Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Instruments

7.4.1 Overview
7.4.2 Instruments: South and Central America Protein Expression Market – Revenue and Forecast to 2031 (US$ Million)

8. South and Central America Protein Expression Market Analysis – by Services

8.1 Antibody Development & Production

8.1.1 Overview
8.1.2 Antibody Development & Production: South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Protein Expression & Production

8.2.1 Overview
8.2.2 Protein Expression & Production: South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Hybridoma One-Stop Services

8.3.1 Overview
8.3.2 Hybridoma One-Stop Services: South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Stable Cell Line Development

8.4.1 Overview
8.4.2 Stable Cell Line Development: South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Bioanalytical Assay Services

8.5.1 Overview
8.5.2 Bioanalytical Assay Services: South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

9. South and Central America Protein Expression Market Analysis – by Application

9.1 Research

9.1.1 Overview
9.1.2 Bioanalytical Assay Services: South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Therapeutic

9.2.1 Overview
9.2.2 Bioanalytical Assay Services: South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Industrial

9.3.1 Overview
9.3.2 Bioanalytical Assay Services: South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

10. South and Central America Protein Expression Market – South and Central America Analysis

10.1 South and Central America

10.1.1 South and Central America Protein Expression Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 South and Central America Protein Expression Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Brazil: South and Central America Protein Expression Market Breakdown, by Product
10.1.1.1.2 Brazil: South and Central America Protein Expression Market Breakdown, by Services
10.1.1.1.3 Brazil: South and Central America Protein Expression Market Breakdown, by Application

10.1.1.2 Argentina: South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Argentina: South and Central America Protein Expression Market Breakdown, by Product
10.1.1.2.2 Argentina: South and Central America Protein Expression Market Breakdown, by Services
10.1.1.2.3 Argentina: South and Central America Protein Expression Market Breakdown, by Application

10.1.1.3 Rest of South and Central America : South and Central America Protein Expression Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Rest of South and Central America : South and Central America Protein Expression Market Breakdown, by Product
10.1.1.3.2 Rest of South and Central America : South and Central America Protein Expression Market Breakdown, by Services
10.1.1.3.3 Rest of South and Central America : South and Central America Protein Expression Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. South and Central America Protein Expression Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 GenScript

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Merck KGaA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Agilent Technologies, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Takara Bio Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Bio-Rad Laboratories Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 QIAGEN

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 New England Biolabs

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Promega Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights